Dexcom Inc

DXCM

$116.18

-1.9% last 12 months

Baillie Gifford Holding value: $1.94 Billion Sands Capital Holding value: $1.59 Billion Ron Baron Holding value: $153 Million Ken Fisher Holding value: $118 Million Ken Griffin Holding value: $110 Million Steven Cohen Holding value: $94.5 Million Ray Dalio Holding value: $69.9 Million George Soros Holding value: $21.5 Million Joel Greenblatt Holding value: $9.27 Million Jefferies Group Holding value: $7.01 Million Mario Gabelli Holding value: $6.04 Million Paul Tudor Jones II Holding value: $0 John Paulson Holding value: $0 Andreas Halvorsen Holding value: $0 Jim Simons Holding value: $0 Tiger Global Holding value: $0

Market Cap

$42.8 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$74.75 - $139.55

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

113.56x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $42.8 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $42.2 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. -1.9%
52-Week High Highest share price in the last 52 weeks. $139.55
52-Week Low Lowest share price in the last 52 weeks. $74.75
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.0
Outstanding Shares The number of shares the company has issued and are held by stockholders. 386 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 5.33 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 113.56
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 589.32
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $0.88
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 14.52
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 23.24
Enterprise Value to Revenue Enterprise value divided by revenue 12.4
Enterprise Value to EBIT Enterprise Value divided by EBIT 83.17
Total Debt to Enterprise Value Total debt divided by enterprise value 0.06
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.15

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $3.4 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $2.17 Billion
EBIT Earnings before tax and interest payments. $507 Million
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $377 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 11.08%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +19.3%
Return on Equity Equity divided by market cap. 16.62%
Return on Assets Indicates a company's profitability in relation to its total assets. 5.72%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 10.31%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2023 Q2 2023 Q3 2023 Q4 2023

About Dexcom Inc

CEO: Kevin Sayer

Industry: Surgical and Medical Instrument Manufacturing

Similar stocks

Edwards Lifesciences Corp
Edwards Lifesciences Corp
Becton Dickinson & Co.
Becton Dickinson & Co.
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc.
Tandem Diabetes Care Inc
Tandem Diabetes Care Inc
Medtronic Plc
Medtronic Plc
Abbott Laboratories
Abbott Laboratories
Johnson & Johnson
Johnson & Johnson
QuidelOrtho Corporation
QuidelOrtho Corporation

News

DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Champlain Investment Partners LLC

DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Champlain Investment Partners LLC

… the SEC. The institutional investor owned 1,893,498 … 15th largest position. Champlain Investment Partners LLC owned about 0 … quarter. Several other insti...

EIN News Investing EIN News Investing, 2 days ago
5 Best Medical Technology Stocks To Buy Now

5 Best Medical Technology Stocks To Buy Now

In this article, we discuss 5 of the best medical device stocks to buy now. If you want to go through our detailed medical technology industry discussion, he...

Insider Monkey Insider Monkey, 5 days ago
Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM)

Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM)

Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM)

GuruFocus GuruFocus, 6 days ago
Capital World Investors Has $497.41 Million Position in DexCom, Inc. (NASDAQ:DXCM)

Capital World Investors Has $497.41 Million Position in DexCom, Inc. (NASDAQ:DXCM)

… the period. Capital World Investors ’ holdings in DexCom were … funds and other institutional investors have also recently added … stock is owned by instit...

EIN News Investing EIN News Investing, 7 days ago
Never miss a trade
To improve your user experience we use cookies.